[Development of an oral nitroglycerin proxyphyllin retard compound].
D000284:Administration, Oral; D001702:Biopharmaceutics; D003692:Delayed-Action Preparations; D004355:Drug Stability; D005750:Gastric Juice / Q000032:analysis; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D009055:Mouth / Q000032:analysis; D005996:Nitroglycerin / Q000008:administration & dosage / Q000032:analysis* / Q000097:blood; D013607:Tablets / Q000032:analysis; D013678:Technology, Pharmaceutical; D013806:Theophylline / Q000032:analysis* / Q000097:blood; D013997:Time Factors
D003692:Delayed-Action Preparations; D013607:Tablets; D013806:Theophylline; D005996:Nitroglycerin
Entwicklung einer peroralen Nitroglycerin-Proxyphyllin-Retard-Form.